February 13, 2018

Pharma industry will work with initiatives that truly speed up Ireland’s slow and late access to med

Ireland lags last in Western Europe – our own process needs fixing The Irish Pharmaceutical Healthcare Association (IPHA) which represents the research based pharmaceutical industry in […]
January 25, 2018

New research shows consumers increasingly willing to take charge of their health

92% of people like to be involved in decisions about their own health and medication. Expanding the range of medicines available to patients and a greater […]
December 8, 2017

EU and UK must prioritise patients in Brexit talks as crunch Article 50 decision approaches

The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed a call from a group of organisations representing patients, healthcare professionals and the health care industry to the EU […]
November 7, 2017

IPHA WELCOMES POSITIVE TREND IN CANCER SURVIVAL

BUT IRELAND IS SLOW AND LATE IN MAKING NEW CANCER MEDICINES AVAILABLE IMPROVING SPEED OF ACCESS TO NEW CANCER MEDICINES AN URGENT PRIORITY Tuesday 7th November, 2017 […]
October 24, 2017

Ireland to host globally renowned BioPharma Ambition conference in 2018

Tuesday 24 October 2017   Irish Biopharma industry has the potential to create 8,400 additional jobs by 2020 Brexit ‘cliff edge’ can be avoided by investing […]
October 10, 2017

Budget 2018 Reaction: Patients waiting for new medicines need a multi-annual solution

Budget 2018 Reaction:   Patients waiting for new medicines need a multi-annual solution Ireland last in Western Europe for new medicines New medicines need sustained new funding […]
October 5, 2017

Innovative medicines are a significant factor in contributing to advances in cancer care – IPHA

Responding to the publication of a study in the British Medical Journal (BMJ) concerning the benefits on overall survival and quality of life of approved cancer […]
September 26, 2017

IPHA launches report and infographic on how Ireland is falling behind in access to new medicines

IPHA has launched a briefing document which sets out how Irish patients are being denied access to new medicines that are readily available in other Western […]
September 22, 2017

IPHA Submission to National Biosimilar Medicines Consultation

Innovation is key for best outcomes: Ireland must adopt innovation faster No change should be made to current legislation since physicians can already prescribe  biosimilars:  pharmacy-led substitution without […]